Lyell Immunopharma Inc. (LYEL)
LYEL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.51
-9.19% on the day
Market cap
$184.0M
Micro cap
Revenue · 2025
$36K
-41.0% on 2024
Net income · 2025
-$274.4M
-762355.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | LYEL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001806952 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $36K |
| Net income | -$274.4M |
| Operating income | -$269.4M |
| Net margin | -762355.6% |
| Operating margin | -748344.4% |
| Revenue growth | -41.0% |
| Cash | $60.2M |
| Total assets | $340.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 5112.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-07-13 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-10 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 354 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRDA | Entrada Therapeutics Inc. | $4.86 | -11.64% | $189.2M |
| ELDN | Eledon Pharmaceuticals Inc. | $2.34 | -4.10% | $190.2M |
| UPB | Upstream Bio Inc. | $3.55 | -14.87% | $194.4M |
| ORMP | Oramed Pharmaceuticals Inc. | $4.17 | -2.34% | $173.5M |
| NGEN | NervGen Pharma Corp. | $1.63 | -5.78% | $173.5M |
| PEPG | PepGen Inc. | $2.50 | +0.40% | $173.1M |
| YARW | Yarrow Bioscience Inc. | $18.60 | -6.16% | $173.1M |
| WHWK | Whitehawk Therapeutics Inc. | $3.02 | -10.65% | $172.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier